Recombinant human Peroxiredoxin 6 protein is a Human Full Length protein, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, WB, FuncS.
M G S S H H H H H H S S G L V P R G S H M P G G L L L G D V A P N F E A N T T V G R I R F H D F L G D S W G I L F S H P R D F T P V C T T E L G R A A K L A P E F A K R N V K L I A L S I D S V E D H L A W S K D I N A Y N C E E P T E K L P F P I I D D R N R E L A I L L G M L D P A E K D E K G M P V T A R V V F V F G P D K K L K L S I L Y P A T T G R N F D E I L R V V I S L Q L T A E K R V A T P V D W K D G D S V M V L P T I P E E E A K K L F P K G V F T K E L P S G K K Y L R Y T P Q P
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application WB | Reactivity Reacts | Dilution info - | Notes ab87631 can be used as a WB positive control in conjunction with Anti-Peroxiredoxin 6 antibody ab73350. |
Application FuncS | Reactivity Reacts | Dilution info - | Notes Specific activity: approximately 95-120 pmole/min/µg. |
Select an associated product type
Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively (PubMed:10893423, PubMed:9497358). Can reduce H(2)O(2) and short chain organic, fatty acid, and phospholipid hydroperoxides (PubMed:10893423). Also has phospholipase activity, can therefore either reduce the oxidized sn-2 fatty acyl group of phospholipids (peroxidase activity) or hydrolyze the sn-2 ester bond of phospholipids (phospholipase activity) (PubMed:10893423, PubMed:26830860). These activities are dependent on binding to phospholipids at acidic pH and to oxidized phospholipds at cytosolic pH (PubMed:10893423). Plays a role in cell protection against oxidative stress by detoxifying peroxides and in phospholipid homeostasis (PubMed:10893423). Exhibits acyl-CoA-dependent lysophospholipid acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (PubMed:26830860). Shows a clear preference for LPC as the lysophospholipid and for palmitoyl CoA as the fatty acyl substrate (PubMed:26830860).
AOP2, KIAA0106, PRDX6, Peroxiredoxin-6, 1-Cys peroxiredoxin, 24 kDa protein, Acidic calcium-independent phospholipase A2, Antioxidant protein 2, Glutathione-dependent peroxiredoxin, Liver 2D page spot 40, Lysophosphatidylcholine acyltransferase 5, Non-selenium glutathione peroxidase, Red blood cells page spot 12, 1-Cys PRX, aiPLA2, LPC acyltransferase 5, LPCAT-5, Lyso-PC acyltransferase 5, NSGPx
Recombinant human Peroxiredoxin 6 protein is a Human Full Length protein, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, WB, FuncS.
pH: 8
Constituents: 20% Glycerol (glycerin, glycerine), 0.316% Tris HCl
Purified by using conventional chromatography.
Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively (PubMed:10893423, PubMed:9497358). Can reduce H(2)O(2) and short chain organic, fatty acid, and phospholipid hydroperoxides (PubMed:10893423). Also has phospholipase activity, can therefore either reduce the oxidized sn-2 fatty acyl group of phospholipids (peroxidase activity) or hydrolyze the sn-2 ester bond of phospholipids (phospholipase activity) (PubMed:10893423, PubMed:26830860). These activities are dependent on binding to phospholipids at acidic pH and to oxidized phospholipds at cytosolic pH (PubMed:10893423). Plays a role in cell protection against oxidative stress by detoxifying peroxides and in phospholipid homeostasis (PubMed:10893423). Exhibits acyl-CoA-dependent lysophospholipid acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (PubMed:26830860). Shows a clear preference for LPC as the lysophospholipid and for palmitoyl CoA as the fatty acyl substrate (PubMed:26830860).
Belongs to the peroxiredoxin family. Prx6 subfamily.
Irreversibly inactivated by overoxidation of Cys-47 to sulfinic acid (Cys-SO(2)H) and sulfonic acid (Cys-SO(3)H) forms upon oxidative stress.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
Peroxiredoxin 6 also known as Prdx6 or peroxiredoxin-6 is a unique member of the peroxiredoxin family. It distinguishes itself by possessing both peroxidase and phospholipase A2 activities. This protein weighs approximately 25 kDa and is ubiquitously expressed in various tissues showing a high concentration in the lung. The expression pattern suggests its importance across different physiological contexts.
We can understand peroxiredoxin 6 as a versatile enzyme that reduces hydrogen peroxide and organic hydroperoxides. It does not form a complex like some other peroxiredoxins. Instead it acts independently in cellular protection against oxidative stress. This role is mainly due to its peroxidase activity which helps in maintaining cellular redox balance and mitigating oxidative damage.
Multiple cellular processes incorporate the enzymatic functions of peroxiredoxin 6. It plays an important role in the antioxidant defense pathway by collaborating with glutathione peroxidase to detoxify hydrogen peroxide. Another major pathway that involves Prdx6 is the phospholipid metabolism where it participates in the repair of oxidatively damaged cell membranes. This protein interacts with cytoplasmic thioredoxin proteins forming a network for managing intracellular reactive oxygen species.
Peroxiredoxin 6 has significant implications. Researchers have linked it to lung cancer where its expression levels correlate with disease progression possibly interacting with oncogenic proteins like NF-kB. In addition peroxiredoxin 6 is associated with neurodegenerative diseases such as Alzheimer’s disease. Its function in oxidative stress regulation might influence the aggregation of proteins like Tau which is a hallmark of Alzheimer's pathology.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ab87631 on 15% SDS-PAGE (3μg)
All lanes: Western blot - Anti-Peroxiredoxin 6 antibody (Anti-Peroxiredoxin 6 antibody ab73350) at 1 µg/mL
All lanes: Western blot - Recombinant human Peroxiredoxin 6 protein (ab87631) at 0.01 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (Goat Anti-Rabbit IgG H&L (HRP) preadsorbed ab97080) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 25 kDa
Exposure time: 30s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com